Small molecule enhancers of autophagy for neurodegenerative diseases

Molecular BioSystems

Volumn 4, Issue 9, 2008, Pages 895-901

  Sarkar, Sovan ^a,b,c   Rubinsztein, David C ^a,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN; PROTEIN KINASE; RAPAMYCIN; TREHALOSE;

ANIMAL; ARTICLE; AUTOPHAGY; BIOLOGICAL MODEL; CHEMISTRY; DEGENERATIVE DISEASE; METABOLISM; PHYSIOLOGY; PROTEIN FOLDING; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; INOSITOL; MODELS, BIOLOGICAL; NEURODEGENERATIVE DISEASES; PROTEIN FOLDING; PROTEIN KINASES; PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS; TREHALOSE;

ANIMALIA; EUKARYOTA;

EID: 49749096430     PISSN: 1742206X     EISSN: 17422051     Source Type: Journal    
DOI: 10.1039/b804606a     Document Type: Article

References (54)

1. C. M. Dobson Protein folding and misfolding Nature 2003 426 884 890
2. H. L. Paulson Protein fate in neurodegenerative proteinopathies polyglutamine diseases join the (mis)fold Am. J. Hum. Genet. 1999 64 339 345
3. C. A. Ross M. A. Poirier Protein aggregation and neurodegenerative disease Nat. Med. 2004 10 Suppl S10 S17
4. C. Soto Protein misfolding and disease; protein refolding and therapy FEBS Lett. 2001 498 204 207
5. Z. Berger B. Ravikumar F. M. Menzies L. G. Oroz B. R. Underwood M. N. Pangalos I. Schmitt U. Wullner B. O. Evert C. J. O'Kane D. C. Rubinsztein Rapamycin alleviates toxicity of different aggregate-prone proteins Hum. Mol. Genet. 2006 15 433 442
6. B. Ravikumar R. Duden D. C. Rubinsztein Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy Hum. Mol. Genet. 2002 11 1107 1117
7. B. Ravikumar C. Vacher Z. Berger J. E. Davies S. Luo L. G. Oroz F. Scaravilli D. F. Easton R. Duden C. J. O'Kane D. C. Rubinsztein Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease Nat. Genet. 2004 36 585 595
8. D. C. Rubinsztein J. E. Gestwicki L. O. Murphy D. J. Klionsky Potential therapeutic applications of autophagy Nat. Rev. Drug Discovery 2007 6 304 312
9. J. L. Webb B. Ravikumar J. Atkins J. N. Skepper D. C. Rubinsztein Alpha-Synuclein is degraded by both autophagy and the proteasome J. Biol. Chem. 2003 278 25009 25013
10. M. Shibata T. Lu T. Furuya A. Degterev N. Mizushima T. Yoshimori M. MacDonald B. Yankner J. Yuan Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1 J. Biol. Chem. 2006 281 14474 14485
11. D. C. Rubinsztein The roles of intracellular protein-degradation pathways in neurodegeneration Nature 2006 443 780 786
12. N. Mizushima B. Levine A. M. Cuervo D. J. Klionsky Autophagy fights disease through cellular self-digestion Nature 2008 451 1069 1075
13. Y. Kabeya N. Mizushima T. Ueno A. Yamamoto T. Kirisako T. Noda E. Kominami Y. Ohsumi T. Yoshimori LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing EMBO J. 2000 19 5720 5728
14. T. Hara K. Nakamura M. Matsui A. Yamamoto Y. Nakahara R. Suzuki-Migishima M. Yokoyama K. Mishima I. Saito H. Okano N. Mizushima Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice Nature 2006 441 885 889
15. M. Komatsu S. Waguri T. Chiba S. Murata J. Iwata I. Tanida T. Ueno M. Koike Y. Uchiyama E. Kominami K. Tanaka Loss of autophagy in the central nervous system causes neurodegeneration in mice Nature 2006 441 880 884
16. D. D. Sarbassov S. M. Ali D. M. Sabatini Growing roles for the mTOR pathway Curr. Opin. Cell Biol. 2005 17 596 603
17. T. Noda Y. Ohsumi Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast J. Biol. Chem. 1998 273 3963 3966
18. D. H. Kim D. D. Sarbassov S. M. Ali J. E. King R. R. Latek H. Erdjument-Bromage P. Tempst D. M. Sabatini mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery Cell 2002 110 163 175
19. D. H. Kim D. D. Sarbassov S. M. Ali R. R. Latek K. V. Guntur H. Erdjument-Bromage P. Tempst D. M. Sabatini GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR Mol. Cell 2003 11 895 904
20. B. Ravikumar A. Stewart H. Kita K. Kato R. Duden D. C. Rubinsztein Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy Hum. Mol. Genet. 2003 12 985 994
21. B. Ravikumar Z. Berger C. Vacher C. J. O'Kane D. C. Rubinsztein Rapamycin pre-treatment protects against apoptosis Hum. Mol. Genet. 2006 15 1209 1216
22. R. S. Williams L. Cheng A. W. Mudge A. J. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 2002 417 292 295
23. S. Sarkar R. A. Floto Z. Berger S. Imarisio A. Cordenier M. Pasco L. J. Cook D. C. Rubinsztein Lithium induces autophagy by inhibiting inositol monophosphatase J. Cell Biol. 2005 170 1101 1111
24. M. K. Rowe D. M. Chuang Lithium neuroprotection: molecular mechanisms and clinical implications Expert Rev. Mol. Med. 2004 6 1 18
25. M. J. Berridge Inositol trisphosphate and diacylglycerol: two interacting second messengers Annu. Rev. Biochem. 1987 56 159 193
26. M. J. Berridge M. D. Bootman H. L. Roderick Calcium signaling: dynamics, homeostasis and remodelling Nat. Rev. Mol. Cell Biol. 2003 4 517 529
27. P. W. Majerus Inositol phosphate biochemistry Annu. Rev. Biochem. 1992 61 225 250
28. T. Maeda F. Eisenberg, Jr Purification, structure, and catalytic properties of l-myo-inositol-1-phosphate synthase from rat testis J. Biol. Chem. 1980 255 8458 8464
29. R. C. Inhorn P. W. Majerus Properties of inositol polyphosphate 1-phosphatase J. Biol. Chem. 1988 263 14559 14565
30. L. M. Hallcher W. R. Sherman The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain J. Biol. Chem. 1980 255 10896 10901
31. M. J. Berridge Inositol trisphosphate and calcium signalling Nature 1993 361 315 325
32. J. R. Atack H. B. Broughton S. J. Pollack Structure and mechanism of inositol monophosphatase FEBS Lett. 1995 361 1 7
33. J. R. Atack S. M. Cook A. P. Watt S. R. Fletcher C. I. Ragan In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330 J. Neurochem. 1993 60 652 658
34. G. Shaltiel A. Shamir J. Shapiro D. Ding E. Dalton M. Bialer A. J. Harwood R. H. Belmaker M. L. Greenberg G. Agam Valproate decreases inositol biosynthesis Biol. Psychiatry 2004 56 868 874
35. 3 levels regulate autophagy: biology and therapeutic speculations Autophagy 2006 2 132 134
36. S. Sarkar G. Krishna S. Imarisio S. Saiki C. J. O'Kane D. C. Rubinsztein A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin Hum. Mol. Genet. 2008 17 170 178
37. P. Cohen S. Frame The renaissance of GSK3 Nat. Rev. Mol. Cell Biol. 2001 2 769 776
38. P. S. Klein D. A. Melton A molecular mechanism for the effect of lithium on development Proc. Natl. Acad. Sci. U. S. A. 1996 93 8455 8459
39. W. J. Ryves A. J. Harwood Lithium inhibits glycogen synthase kinase-3 by competition for magnesium Biochem. Biophys. Res. Commun. 2001 280 720 725
40. K. Inoki H. Ouyang T. Zhu C. Lindvall Y. Wang X. Zhang Q. Yang C. Bennett Y. Harada K. Stankunas C. Y. Wang X. He O. A. MacDougald M. You B. O. Williams K. L. Guan TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth Cell 2006 126 955 968
41. Z. Berger E. K. Ttofi C. H. Michel M. Y. Pasco S. Tenant D. C. Rubinsztein C. J. O'Kane Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway Hum. Mol. Genet. 2005 14 3003 3011
42. J. Carmichael K. L. Sugars Y. P. Bao D. C. Rubinsztein Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation J. Biol. Chem. 2002 277 33791 33798
43. N. I. Wood A. J. Morton Chronic lithium chloride treatment has variable effects on motor behaviour and survival of mice transgenic for the Huntington's disease mutation Brain Res. Bull. 2003 61 375 383
44. F. Fornai P. Longone L. Cafaro O. Kastsiuchenka M. Ferrucci M. L. Manca G. Lazzeri A. Spalloni N. Bellio P. Lenzi N. Modugno G. Siciliano C. Isidoro L. Murri S. Ruggieri A. Paparelli Lithium delays progression of amyotrophic lateral sclerosis Proc. Natl. Acad. Sci. U. S. A. 2008 105 2052 2057
45. S. Sarkar E. O. Perlstein S. Imarisio S. Pineau A. Cordenier R. L. Maglathlin J. A. Webster T. A. Lewis C. J. O'Kane S. L. Schreiber D. C. Rubinsztein Small molecules enhance autophagy and reduce toxicity in Huntington's disease models Nat. Chem. Biol. 2007 3 331 338
46. L. Zhang J. Yu H. Pan P. Hu Y. Hao W. Cai H. Zhu A. D. Yu X. Xie D. Ma J. Yuan Small molecule regulators of autophagy identified by an image-based high-throughput screen Proc. Natl. Acad. Sci. U. S. A. 2007 104 19023 19028
47. A. Williams S. Sarkar P. Cuddon E. K. Ttofi S. Saiki F. H. Siddiqi L. Jahreiss A. Fleming D. Pask P. Goldsmith C. J. O'Kane R. A. Floto D. C. Rubinsztein Novel targets for Huntington's disease in an mTOR-independent autophagy pathway Nat. Chem. Biol. 2008 4 295 305
48. Q. Chen G. G. Haddad Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals J. Exp. Biol. 2004 207 3125 3129
49. W. J. Welch C. R. Brown Influence of molecular and chemical chaperones on protein folding Cell Stress Chaperones 1996 1 109 115
50. A. Arora C. Ha C. B. Park Inhibition of insulin amyloid formation by small stress molecules FEBS Lett. 2004 564 121 125
51. R. Liu H. Barkhordarian S. Emadi C. B. Park M. R. Sierks Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42 Neurobiol. Dis. 2005 20 74 81
52. M. Tanaka Y. Machida S. Niu T. Ikeda N. R. Jana H. Doi M. Kurosawa M. Nekooki N. Nukina Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease Nat. Med. 2004 10 148 154
53. S. Sarkar J. E. Davies Z. Huang A. Tunnacliffe D. C. Rubinsztein Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein J. Biol. Chem. 2007 282 5641 5652
54. B. Levine G. Kroemer Autophagy in the pathogenesis of disease Cell 2008 132 27 42